Sergei Polevikov·Sep 7There Is No Money in AI Drug DiscoveryFive years, $5.58B of losses, not one AI-discovered drug approved. Then Novartis lost an 8,323-patient Phase 3 with the drug working…
Allu Vamsi Pavan Kumar·Sep 7Designing Molecules in More Than One Representation: The Rise of Multimodal AI in Drug DiscoveryChemistry is more interesting because the modalities are not merely different ways of observing the same object, they describe different…
Muhammed Afsal·Sep 2Can We Predict Which Drugs Will Succeed Before Clinical Trials?Drug development has always involved a difficult paradox.
Colby T. Ford, Ph.D.·Aug 27Evaluating a Ternary Protein Language Model Architecture for Rapid Antibody Sequence GenerationA couple years ago, Microsoft Research released a novel approach for large language models that use a 1.58-bit architecture, resulting in a…
Yacine Kellib·Aug 22A Credential Is Not AuthorisationAgents arrived in the lab this year. Authorising the connection is not the same as authorising the consequence.
